Publications by authors named "Kent MacMillan"
Article Synopsis
- The study aimed to identify and analyze the differences between the quantities of medications supplied to public hospitals and those actually given to patients, focusing on 20 commonly used drugs in Melbourne hospitals in 2019.
- It found that the overall discrepancy rate was 19.2%, with notable variations between hospitals and types of wards; discrepancies were highest for self-treatment medications like oral antibiotics and gastrointestinal drugs.
- The estimated financial impact of these discrepancies on hospitals was approximately $27,800, highlighting a significant issue in medication tracking and management.
Introduction: Evidence of occupational exposure risks to novel anticancer agents is limited and yet to be formally evaluated from the Australian healthcare perspective.
Methods: From March to September 2013 medical databases, organizational policies, drug monographs, and the World Wide Web were searched for evidence relating to occupational exposure to monoclonal antibodies, fusion proteins, gene therapies, and other unclassified novel anticancer agents.
Results: Australian legislation, national and international guidelines, and drug company information excluded novel agents or provided inconsistent risk assessments and safe handling recommendations.